Novartis workers prepare the production of flu vaccines during a 2009 media tour of the then-new plant in Holly Springs. The fate of the 430,000-square-foot facility came into focus Monday after Australian pharmaceutical giant CSL Limited announced it will buy the plant as part of a $275 million acquisition of Novartis’s influenza business.
Novartis workers prepare the production of flu vaccines during a 2009 media tour of the then-new plant in Holly Springs. The fate of the 430,000-square-foot facility came into focus Monday after Australian pharmaceutical giant CSL Limited announced it will buy the plant as part of a $275 million acquisition of Novartis’s influenza business.
Novartis workers prepare the production of flu vaccines during a 2009 media tour of the then-new plant in Holly Springs. The fate of the 430,000-square-foot facility came into focus Monday after Australian pharmaceutical giant CSL Limited announced it will buy the plant as part of a $275 million acquisition of Novartis’s influenza business.

Novartis selling Holly Springs vaccine plant in $275M deal

October 27, 2014 10:38 AM

More Videos

  • Tesla Superchargers are coming to Raleigh. Elon Musk explains.

    Elon Musk, CEO of Tesla Inc., explains how the Tesla Supercharger, available soon in Raleigh, charges fast, extending the range of Tesla electric cars.